Valneva

Valneva ROE

The Return on Equity (ROE) of Valneva (VLA.PA) as of Oct 18, 2026 is -108.50 %. In the previous year, Return on Equity (ROE) was -6.76 % — a change of 1,505.77% (lower).

ROE

-108.50 %

YoY

1,505.77%

Last updated:

In 2025, Valneva's return on equity (ROE) was -108.50 %, a 1,505.77% increase from the -6.76 % ROE in the previous year.

The Valneva ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
2.28 EUR
Jan 1, 2019
-1.29 EUR
Jan 1, 2020
-83.17 EUR
Jan 1, 2021
-43.04 EUR
Jan 1, 2022
-65.19 EUR
Jan 1, 2023
-79.09 EUR
Jan 1, 2024
-6.76 EUR
Jan 1, 2025
-108.50 EUR
The Valneva ROE history
YEARROEYoY
-108.50 %+1,505.77%
-6.76 %-91.46%
-79.09 %+21.33%
-65.19 %+51.44%
-43.04 %-48.25%
-83.17 %+6,345.45%
-1.29 %-156.61%
2.28 %-118.40%
-12.39 %-74.80%
-49.16 %+244.15%
-14.28 %-32.34%
-21.11 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valneva Stock analysis

What does Valneva do? Valneva SE is a biopharmaceutical company specializing in the development, production, and marketing of vaccines for humans and animals. The company was founded in 2013 through the merger of French biotech company Vivalis and Austrian biotech company Intercell. Valneva focuses on developing vaccines for infectious diseases with a significant global burden but limited commercial demand. They work closely with governments and international organizations to improve access to their vaccines in developing countries. Valneva also has a strong presence in the animal vaccine market, producing vaccines for diseases in livestock and pets. They have developed and marketed several vaccines, including Ixiaro for Japanese encephalitis and VLA15, a vaccine candidate for Lyme disease. Overall, Valneva is an international company with an impressive pipeline of vaccine candidates and a commitment to addressing global health needs. Valneva is one of the most popular companies on Eulerpool.

ROE Details

Decoding Valneva's Return on Equity (ROE)

Valneva's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Valneva's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Valneva's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Valneva’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Valneva stock

Return on Equity (ROE) of Valneva is -108.50 % in 2025.

Return on Equity (ROE) of Valneva changed from -6.76 % to -108.50 %, representing a 1,505.77% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Valneva since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Valneva with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Valneva

All Key Metrics — Valneva